1. Home
  2. VKTX vs APAM Comparison

VKTX vs APAM Comparison

Compare VKTX & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • APAM
  • Stock Information
  • Founded
  • VKTX 2012
  • APAM 1994
  • Country
  • VKTX United States
  • APAM United States
  • Employees
  • VKTX N/A
  • APAM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • APAM Investment Managers
  • Sector
  • VKTX Health Care
  • APAM Finance
  • Exchange
  • VKTX Nasdaq
  • APAM Nasdaq
  • Market Cap
  • VKTX 3.4B
  • APAM 2.7B
  • IPO Year
  • VKTX 2015
  • APAM 2013
  • Fundamental
  • Price
  • VKTX $24.15
  • APAM $39.08
  • Analyst Decision
  • VKTX Strong Buy
  • APAM Hold
  • Analyst Count
  • VKTX 11
  • APAM 4
  • Target Price
  • VKTX $95.18
  • APAM $44.38
  • AVG Volume (30 Days)
  • VKTX 3.8M
  • APAM 635.9K
  • Earning Date
  • VKTX 04-23-2025
  • APAM 04-22-2025
  • Dividend Yield
  • VKTX N/A
  • APAM 8.90%
  • EPS Growth
  • VKTX N/A
  • APAM 14.69
  • EPS
  • VKTX N/A
  • APAM 3.66
  • Revenue
  • VKTX N/A
  • APAM $1,111,802,000.00
  • Revenue This Year
  • VKTX N/A
  • APAM $7.39
  • Revenue Next Year
  • VKTX N/A
  • APAM $7.04
  • P/E Ratio
  • VKTX N/A
  • APAM $10.69
  • Revenue Growth
  • VKTX N/A
  • APAM 14.02
  • 52 Week Low
  • VKTX $23.27
  • APAM $37.89
  • 52 Week High
  • VKTX $82.00
  • APAM $49.54
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 33.93
  • APAM 38.15
  • Support Level
  • VKTX $25.80
  • APAM $39.78
  • Resistance Level
  • VKTX $29.60
  • APAM $41.87
  • Average True Range (ATR)
  • VKTX 1.61
  • APAM 0.99
  • MACD
  • VKTX -0.30
  • APAM -0.02
  • Stochastic Oscillator
  • VKTX 10.72
  • APAM 21.19

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.

Share on Social Networks: